http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005096997-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62880a906ff5ec1a0671feb22857d5d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68bbfc5eb02cc294a7e5f106813d6709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec16eeb4272d62bdae5543700abe0b9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f269c9eb1be30d9ee063c1a077a9fe0e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2220-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-856
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90
filingDate 2005-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc0be9a51722e03b30da53ed76f8a48d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c72591d179eee2416f92038a3be9a3fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27a0eaddd4d88881881eead5d155760
publicationDate 2005-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005096997-A2
titleOfInvention Endolumenal vascular prosthesis with neointima inhibiting polymeric sleeve
abstract The prosthesis has a radially expandable tubular wire support (46) and an expanded PTFE membrane (44). The density, wall thickness and intranodal distance of the ePTFE are selected to inhibit the formation and nourishment of a viable neointima on the inner surface of the prosthesis, through the ePTFE membrane.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10543116-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10456281-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9622888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11779481-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103372-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10299948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9943428-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568752-B2
priorityDate 2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129352157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 42.